The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Current understanding of Alzheimer’s disease diagnosis and treatment
Open accessAbstract
Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies: β-amyloid plaque deposition and neurofibrillary tangles of hyperphosphorylated tau. Diagnosis is based upon clinical presentation fulfilling several criteria as well as fluid and imaging biomarkers. Treatment is currently targeted toward symptomatic therapy, although trials are underway that aim to reduce the production and overall burden of pathology within the brain. Here, we discuss recent advances in our understanding of the clinical evaluation and treatment of Alzheimer’s disease, with updates regarding clinical trials still in progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, both PET imaging and CSF analysis exhibit similar accuracy, and suggest that the optimum test for the diagnosis will depend upon patient/provider preference, cost and availability of facilities [37].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [37]
In the citing paper
“Current therapeutics to ameliorate and control the cognitive and behavioral symptoms by targeting the NMDA receptor prevent Ca2+ induced excitotoxicity [2, 9–11], and memantine was approved for this purpose in 2003.”
From Current therapeutics for Alzheimer’s disease and clinical trials (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzen, E. (2008) · Wiley eBooks · doi:10.1002/9780470373699.speced0655 · Cited by 8,467
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,643
Olsson, B., Lautner, R., Andreasson, U., Öhrfelt, A., Portelius, E., Bjerke, M., Hölttä, M., Rosén, C., Olsson, C., Strobel, G., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00070-3 · Cited by 2,049
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668
Cited by
Sorted by citations
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
“However, both PET imaging and CSF analysis exhibit similar accuracy, and suggest that the optimum test for the diagnosis will depend upon patient/provider preference, cost and availability of facilities [37].”
BackgroundMolecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
The role of astroglia in Alzheimer's disease: pathophysiology and clinical implications
Arranz, A. M., & De Strooper, B. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30490-3 · Cited by 334
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. V. D. S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 375
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Megur, A., Baltriukienė, D., Bukelskienė, V., & Burokas, A. (2020) · Nutrients · doi:10.3390/nu13010037 · Cited by 323
The complexity of Alzheimer’s disease: an evolving puzzle
Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 343
Biosensing based on field-effect transistors (FET): Recent progress and challenges
Sadighbayan, D., Hasanzadeh, M., & Ghafar‐Zadeh, E. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116067 · Cited by 318
Intrinsically Disordered Proteins: An Overview
Trivedi, R., & Nagarajaram, H. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214050 · Cited by 277
Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev, T. O., Olszewski, P., Shalimova, A. A., Chubarev, V. N., Tarasov, V. V., Attwood, M. M., Syvänen, S., & Schiöth, H. B. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00296-z · Cited by 241
Microglia and Alzheimer’s Disease
Merighi, S., Nigro, M., Travagli, A., & Gessi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112990 · Cited by 236
A review on advances of treatment modalities for Alzheimer's disease
Thoe, E. S., Fauzi, A., Tang, Y.-Q., Chamyuang, S., & Chia, A. Y. Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119129 · Cited by 234
Zhang, W., Xu, C., Sun, J., Shen, H., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 221
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Jan, H., Shah, M., Andleeb, A., Faisal, S., Khattak, A., Rizwan, M., Drouet, S., Hano, C., & Abbasi, B. H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4786227 · Cited by 182
Mitochondrial Dysfunction and Alzheimer’s Disease: Role of Microglia
Agrawal, I., & Jha, S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00252 · Cited by 184
The role of the adaptive immune system and T cell dysfunction in neurodegenerative diseases
DeMaio, A., Mehrotra, S., Sambamurti, K., & Husain, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02605-9 · Cited by 192
Zarneshan, S. N., Fakhri, S., & Khan, H. Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106099 · Cited by 179
Feng, S., Wu, C., Zou, P., Deng, Q., Chen, Z., Li, M., Zhu, L., Li, F., Liu, T. C., Duan, R., et al. (2023) · Theranostics · doi:10.7150/thno.81951 · Cited by 174
Tripathi, M. K., Kartawy, M., & Amal, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101567 · Cited by 163
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 150
The Endosomal Recycling Pathway—At the Crossroads of the Cell
O’Sullivan, M. J., & Lindsay, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176074 · Cited by 141
Biosensors Based on Mechanical and Electrical Detection Techniques
Chalklen, T., Jing, Q., & Kar‐Narayan, S. (2020) · Sensors · doi:10.3390/s20195605 · Cited by 141
Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer’s disease in rats
Chen, X., Zhang, M., Ahmed, M., Surapaneni, K. M., Veeraraghavan, V. P., & Arulselvan, P. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.06.031 · Cited by 129
Expert systems: Definitions, advantages and issues in medical field applications
Saibene, A., Assale, M., & Giltri, M. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.114900 · Cited by 133
Quercetin in Animal Models of Alzheimer’s Disease: A Systematic Review of Preclinical Studies
Zhang, X., Chen, J., Ouyang, D., & Lu, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020493 · Cited by 126
DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases
Kousparou, C. A., Fyrilla, M., Stephanou, A., & Patrikios, I. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310717 · Cited by 134
Faisal, S., Al‐Radadi, N. S., Jan, H., Abdullah, A., Shah, S. A., Shah, S., Rizwan, M., Afsheen, Z., Hussain, Z., Uddin, M. N., et al. (2021) · Coatings · doi:10.3390/coatings11070849 · Cited by 118
Nand, S., Mishra, D., Singh, P., Vamanu, E., & Singh, M. P. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111377 · Cited by 118
Wu, J., Yu, Y., Wan, Y., Xia, J., Xu, J., Zhang, L., Liu, D., Chen, L., Tang, F., Ao, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113207 · Cited by 119
Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
Leinen, Z. J., Mohan, R., Premadasa, L. S., Acharya, A., Mohan, M., & Byrareddy, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11102630 · Cited by 114
The Cognitive Control of Eating and Body Weight: It’s More Than What You “Think”
Davidson, T. L., Jones, S., Roy, M., & Stevenson, R. J. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00062 · Cited by 125
The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
Pisani, A., Paciello, F., VECCHIO, V. D., Malesci, R., Corso, E. D., Cantone, E., & Fetoni, A. R. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040652 · Cited by 127
Patella, B., Sortino, A., Mazzara, F., Aiello, G., Drago, G., Torino, C., Vilasi, A. D., O'Riordan, A. J., & Inguanta, R. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339124 · Cited by 109
Kim, M., Youn, Y. C., & Paik, J. (2023) · NeuroImage · doi:10.1016/j.neuroimage.2023.120054 · Cited by 118
Ubiquitous protein lactylation in health and diseases
Wang, J., Wang, Z., Wang, Q., Li, X., & Guo, Y. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00541-5 · Cited by 109
Beyond the average patient: how neuroimaging models can address heterogeneity in dementia
Verdi, S., Marquand, A. F., Schott, J. M., & Cole, J. H. (2021) · Brain · doi:10.1093/brain/awab165 · Cited by 106
Huggins, C. J., Escudero, J., Parra, M. A., Scally, B., Anghinah, R., Vitória Lacerda De Araújo, A., Basile, L. F., & Abasolo, D. (2021) · Journal of Neural Engineering · doi:10.1088/1741-2552/ac05d8 · Cited by 105
Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's
Nirale, P., Paul, A., & Yadav, K. S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117394 · Cited by 103
Farina, F. R., Emek‐Savaş, D. D., Rueda‐Delgado, L. M., Boyle, R. T., Kiiski, H. S. M., Yener, G., & Whelan, R. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116795 · Cited by 105
Guan, L., Mao, Z., Yang, S., Wu, G., Chen, Y., Yin, L., Qi, Y., Han, L., & Xu, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113248 · Cited by 101
Immunotherapy for Parkinson’s disease
Schwab, A. D., Thurston, M. J., Machhi, J., Olson, K. E., Namminga, K. L., Gendelman, H. E., & Mosley, R. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104760 · Cited by 101
P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?
Chai, A. B., Leung, G. K. F., Callaghan, R., & Gelissen, I. C. (2019) · FEBS Journal · doi:10.1111/febs.15148 · Cited by 100
Gouveia, F., Camins, A., Ettcheto, M., Bicker, J., Falcão, A. C., Cruz, M. T., & Fortuna, A. C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101612 · Cited by 99
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Thakral, S., Yadav, A., Singh, V., Kumar, M., Kumar, P., Narang, R., Sudhakar, K., Verma, A., Khalilullah, H., Jaremko, M., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101960 · Cited by 103
Oligodendroglial Cells in Alzheimer’s Disease
Butt, A. M., Rocha, I. C. D. L., & Rivera, A. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_12 · Cited by 97
Garbuz, D. G., Zatsepina, O. G., & Evgen’ev, M. B. (2021) · Molecular Biology · doi:10.1134/s002689332104004x · Cited by 95
Zheng, M., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02738-3 · Cited by 110
Deepa, N., & Chokkalingam, S. P. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103455 · Cited by 92
Luo, S., Zhang, X., Huang, S. Q., Feng, X., Zhang, X., & Xiang, D.-X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.185 · Cited by 95
Zhou, Y., Ge, Y., Liu, Q., Li, Y., Xu, C., Guan, J., Diwu, Y., & Zhang, Q. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.10.028 · Cited by 91
Moya, G. E., Rivera, P. D., & Dittenhafer‐Reed, K. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137030 · Cited by 90
Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases
Xia, X., Wang, Y., & Zheng, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.003 · Cited by 87
Faisal, S., Abdullah, A., Jan, H., Shah, S. A., Shah, S., Rizwan, M., Zaman, N., Hussain, Z., Uddin, M. N., Bibi, N., et al. (2021) · Catalysts · doi:10.3390/catal11070780 · Cited by 86
Mesenchymal Stem Cell Therapy for Alzheimer's Disease
Hernández, A. E., & García, E. (2021) · Stem Cells International · doi:10.1155/2021/7834421 · Cited by 74
Mimura, Y., Nishida, H., Nakajima, S., Tsugawa, S., Morita, S., Yoshida, K., Tarumi, R., Ogyu, K., Wada, M., Kurose, S., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.003 · Cited by 86
Speech- and language-based classification of Alzheimer's disease: a systematic review
Vigo, I., Coelho, L., & Reis, S. (2022) · Bioengineering · doi:10.3390/bioengineering9010027 · Cited by 83
Wee, J., Sukudom, S., Bhat, S., Marklund, M., Peiris, N. J., Hoyos, C. M., Patel, S., Naismith, S. L., Dwivedi, G., & Misra, A. (2023) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12395 · Cited by 82
Mahim, S. M., Ali, M. S., Hasan, M. O., Nafi, A. A. N., Sadat, A. K. M., Hasan, S. A., Shareef, B., Ahsan, M. M., Islam, M. K., Miah, M. S., et al. (2024) · IEEE Access · doi:10.1109/access.2024.3351809 · Cited by 92
Iorio, R., Petricca, S., Emidio, G. D., Falone, S., & Tatone, C. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102522 · Cited by 87
The Links between Cardiovascular Diseases and Alzheimer's Disease
Leszek, J., Вячеславовна, М. Е., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak−Prokopowicz, M., Mysiak, A., Diniz, B. S., Somasundaram, S. G., Kirkland, C. E., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200729093724 · Cited by 93
Tzimourta, K. D., Christou, V., Tzallas, A. T., Giannakeas, N., Astrakas, L. G., Angelidis, P., Tsalikakis, D., & Tsipouras, M. G. (2021) · International Journal of Neural Systems · doi:10.1142/s0129065721300023 · Cited by 78
Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 83
An Attention-Based 3D CNN With Multi-Scale Integration Block for Alzheimer's Disease Classification
Wu, Y., Zhou, Y., Zeng, W., Qian, Q., & Song, M. (2022) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2022.3197331 · Cited by 82
O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
Park, J., Lai, M. K. P., Arumugam, T. V., & Jo, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08584-0 · Cited by 79
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 79
Chabib, C., Hadjileontiadis, L. J., & Shehhi, A. A. (2023) · IEEE Access · doi:10.1109/access.2023.3272482 · Cited by 74
Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles
Kim, K. M., Meng, Q., de Acha, O. P., Mustapić, M., Cheng, A., Eren, E., Kundu, G., Piao, Y., Munk, R. B., Wood, W. H., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.581882 · Cited by 72
Phytotherapy: A promising approach for the treatment of Alzheimer's disease
John, O. O., Amarachi, I. S., Chinazom, A. P., Adaeze, E., Kale, M. B., Umare, M. D., & Upaganlawar, A. B. (2022) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2021.100030 · Cited by 69
Zhang, B., Zhao, J., Wang, Z., Xu, L., Liu, A., & Du, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106729 · Cited by 69
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Londzin, P., Zamora, M., Kąkol, B., Taborek, A., & Folwarczna, J. (2021) · Nutrients · doi:10.3390/nu13020537 · Cited by 71
Jayaswamy, P. K., Vijaykrishnaraj, M., Patil, P., Alexander, L. M., Kellarai, A., & Shetty, P. K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101791 · Cited by 71
Maqbool, Z., Arshad, M. S., Ali, A., Aziz, A., Khalid, W., Afzal, M. F., Bangar, S. P., Addi, M., Hano, C., & Lorenzo, J. M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6480590 · Cited by 67
Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., & Melone, M. A. B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111897 · Cited by 70
Did the Brain and Oral Microbiota Talk to Each Other? A Review of the Literature
Maitre, Y., Micheneau, P., Delpierre, A., Mahalli, R., Guérin, M., Amador, G., & Denis, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123876 · Cited by 65
Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer’s Disease
Blagov, A. V., Grechko, A. V., Nikiforov, N. G., Borisov, E. E., Sadykhov, N. K., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136954 · Cited by 70
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 80
Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic
Cordeiro, M. F., Hill, D., Patel, R. P., Corazza, P., Maddison, J., & Younis, S. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100976 · Cited by 67
Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease
Yamamoto, Y., Kanayama, N., Nakayama, Y., & Matsushima, N. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030444 · Cited by 70
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
Beygi, M. H. M., Oroojalian, F., Azizi‐Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202310881 · Cited by 66
Amyloid-β: A double agent in Alzheimer's disease?
Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62
Impact of Alzheimer’s Disease on Caregivers in the United States
Vu, M., Mangal, R., Stead, T., Carlos Lopez-Ortiz, C., & Ganti, L. (2022) · Health Psychology Research · doi:10.52965/001c.37454 · Cited by 62
Li, X., Yang, S., Wang, S., Shi, Y., Dai, Y., Zhang, X., Liu, Y., Guo, Y., He, J., & Xiu, M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123632 · Cited by 63
The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review
Buglio, D. S., Marton, L. T., Laurindo, L. F., Guiguer, É. L., Araújo, A. C., Buchaim, R. L., Goulart, R. D. Á., Rubira, C. J., & Barbalho, S. M. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0084 · Cited by 63
Abdullah, S. A., Najm, L., Ladouceur, L., Ebrahimi, F., Shakeri, A., Al‐Jabouri, N., Didar, T. F., & Dellinger, K. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202302673 · Cited by 65
Roles and Mechanisms of Axon-Guidance Molecules in Alzheimer’s Disease
Zhang, L., Qi, Z., Li, J., Li, M., Du, X., Wang, S., Zhou, G., Xu, B., Liu, W., Xi, S., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02311-2 · Cited by 58
Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
Galla, L., Redolfi, N., Pozzan, T., Pizzo, P., & Greotti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030770 · Cited by 57
Nanaki, S. G., Spyrou, K., Bekiari, C., Veneti, P., Baroud, T. N., Karouta, N., Grivas, I. N., Papadopoulos, G. C., Gournis, D., & Bikiaris, D. Ν. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030227 · Cited by 57
Learning Language and Acoustic Models for Identifying Alzheimer’s Dementia From Speech
Shah, Z., Sawalha, J., Tasnim, M., Qi, S.-A., Stroulia, E., & Greiner, R. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.624659 · Cited by 56
Yan, X., Liu, H., Hong, Y.-X., Meng, T., Du, J., & Chang, C. (2022) · Journal of Neurogenetics · doi:10.1080/01677063.2022.2028784 · Cited by 56
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Gianferrara, T., Cescon, E., Grieco, I., Spalluto, G., & Federico, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220216113517 · Cited by 58
Treating disorders across the lifespan by modulating cholinergic signaling with galantamine
Metz, C. N., & Pavlov, V. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15243 · Cited by 59
Qi, C., Chen, X.-X., Gao, X., Xu, J., Liu, S., & Ge, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.633495 · Cited by 54
Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?
Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 57
Kumar, A., Zhou, L., Zhi, K., Raji, B., Pernell, S., Tadrous, E., Kodidela, S., Nookala, A. R., Kochat, H., & Kumar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010138 · Cited by 54
Genetic associated complications of type 2 diabetes mellitus
WONG, Y. H., WONG, S. H., WONG, X. T., YAP, Q. Y., Yip, K. Y., WONG, L. Z., Chellappan, D. K., Bhattamisra, S. K., & Candasamy, M. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.21.04285-3 · Cited by 52
Mitochondria break free: Mitochondria-derived vesicles in aging and associated conditions
Ferrucci, L., Guerra, F., Bucci, C., Marzetti, E., & Picca, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102549 · Cited by 58
The Role of DNA Damage in Neural Plasticity in Physiology and Neurodegeneration
Konopka, A., & Atkin, J. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.836885 · Cited by 56
Fan, M., Liu, S., Sun, H.-M., Ma, M.-D., Gao, Y.-J., Qi, C.-C., Xia, Q.-R., & Ge, J.-F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113375 · Cited by 50
Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
Peña‐Bautista, C., Tarazona-Sánchez, A., Braza‐Boïls, A., Balaguer, Á., Ferré‐González, L., Martínez, A. J. C., Baquero, M., & Cháfer‐Pericás, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-19862-6 · Cited by 54
Patel, C. A., Pande, S. V., & Acharya, S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01904-3 · Cited by 52
Metadata
- Authors
- Weller, J., & Budson, A.
- Affiliations
- Boston University (US)
- Corresponding author
- Weller, Jason
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2018-07-31
- Volume
- 7
- Pages
- 1161
- ISSN
- 2046-1402 (ISSN-L)
- PMC
- PMC6073093
- OpenAlex
- W2885706121
- Cited by
- 1,083
- References
- 53
- Citations by year
- 2026: 67 · 2025: 155 · 2024: 147 · 2023: 176 · 2022: 221 · 2021: 194 · 2020: 92 · 2019: 29 · 2018: 2
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- F1000Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institute on Aging (P30AG013846)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Alzheimer's disease, dementia, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, biomarkers, diagnosis, symptomatic treatment, disease-modifying therapy, clinical trials, neurodegeneration
- MeSH terms
- Alzheimer Disease, Humans, Nerve Net, Amyloid beta-Peptides, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
